1. Home
  2. RLMD vs USGO Comparison

RLMD vs USGO Comparison

Compare RLMD & USGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLMD
  • USGO
  • Stock Information
  • Founded
  • RLMD 2004
  • USGO 2015
  • Country
  • RLMD United States
  • USGO Canada
  • Employees
  • RLMD N/A
  • USGO N/A
  • Industry
  • RLMD Biotechnology: Pharmaceutical Preparations
  • USGO Precious Metals
  • Sector
  • RLMD Health Care
  • USGO Basic Materials
  • Exchange
  • RLMD Nasdaq
  • USGO Nasdaq
  • Market Cap
  • RLMD 110.6M
  • USGO 122.8M
  • IPO Year
  • RLMD N/A
  • USGO 2023
  • Fundamental
  • Price
  • RLMD $3.16
  • USGO $8.48
  • Analyst Decision
  • RLMD Hold
  • USGO Strong Buy
  • Analyst Count
  • RLMD 2
  • USGO 1
  • Target Price
  • RLMD $7.50
  • USGO $24.00
  • AVG Volume (30 Days)
  • RLMD 110.4K
  • USGO 46.5K
  • Earning Date
  • RLMD 11-07-2024
  • USGO 11-19-2024
  • Dividend Yield
  • RLMD N/A
  • USGO N/A
  • EPS Growth
  • RLMD N/A
  • USGO N/A
  • EPS
  • RLMD N/A
  • USGO N/A
  • Revenue
  • RLMD N/A
  • USGO N/A
  • Revenue This Year
  • RLMD N/A
  • USGO N/A
  • Revenue Next Year
  • RLMD N/A
  • USGO N/A
  • P/E Ratio
  • RLMD N/A
  • USGO N/A
  • Revenue Growth
  • RLMD N/A
  • USGO N/A
  • 52 Week Low
  • RLMD $1.88
  • USGO $5.00
  • 52 Week High
  • RLMD $7.22
  • USGO $14.46
  • Technical
  • Relative Strength Index (RSI)
  • RLMD 39.24
  • USGO 45.29
  • Support Level
  • RLMD $3.06
  • USGO $8.01
  • Resistance Level
  • RLMD $3.43
  • USGO $10.49
  • Average True Range (ATR)
  • RLMD 0.20
  • USGO 0.82
  • MACD
  • RLMD -0.04
  • USGO -0.13
  • Stochastic Oscillator
  • RLMD 16.30
  • USGO 26.51

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

About USGO U.S. GoldMining Inc. Common stock

US Goldmining Inc is a mineral exploration and development company. It is focused on the exploration and development of a project located in Alaska, USA. The company's sole property is Whistler Project which is a gold-copper exploration project located in the Yentna Mining District, approximately 170 km northwest of Anchorage, Alaska.

Share on Social Networks: